(Q72809741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

The nephrotic syndrome, lipids, and risk factors for cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

lipid

0 references

cardiovascular disease

1 reference

1 reference

J Radhakrishnan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A S Appel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Valeri

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

G B Appel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 July 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

135-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

The nephrotic syndrome and its complications

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Lipid abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Partial remission of nephrotic syndrome in patient on long-term simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Accelerated Atherosclerosis in Chronic-Dialysis Patients – Another Look

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

The role of hypertension in hemodialysis-associated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Left ventricular hypertrophy in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Cardiovascular changes in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Does the nephrotic syndrome increase the risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Ischaemic heart-disease as a complication of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Status of the coronary arteries in the nephrotic syndrome. Analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

The clinical course of left ventricular hypertrophy in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Dialysis-associated ischemic heart disease: insights from coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970179-8

7 January 2021

10.1016/S0272-6386(12)70179-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322776%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference